AngioDynamics, a leading provider of
\nminimally invasive medical devices for
\nvascular access, surgery, peripheral vascular
\ndisease and oncology, announced the
\nGermany Ministry of Health has issued an
\nOPS (a procedure classification code) for
\nthe company’s NanoKnife System.<\/p>\n
This process is the first step in securing
\nreimbursement for new medical technologies
\nin Germany, company officials said.
\nAngioDynamics, headquartered in
\nLatham, employs approximately 800 at
\noperations in Glens Falls and Queensbury.<\/p>\n
According to the company, there are
\ncurrently seven NanoKnife systems in
\nGermany, used primarily in patients who
\nsuffer from liver, prostate, kidney and lung
\ncancers. Use of the system is usually paid
\nfor by the patient or the costs are picked
\nup through a research grant at a university
\nhospital. Being granted an OPS is an important
\nstep in the universal acceptance
\nof a medical technology.
\n“The issuance of the OPS by the German
\nMinistry of Health is an enormous
\nadvancement in the successful implementation
\nof the NanoKnife technology in the
\nGerman market,” said Rick Stark, senior
\nvice president of AngioDynamics’ Global
\nOncology\/Surgery Franchise. “With OPS
\nin-hand, the Ministry can now document substanthe
\ntechnology’s benefits and determine
\nan appropriate level of reimbursement
\naccording to German Diagnosis Related
\nGroups (G-DRGs) for a variety of specific
\nprocedures.”<\/p>\n
Eleven new OPS Codes have been introduced,
\nincluding those for bile ducts,
\nbones, liver, lungs, stomach,adrenal gland,
\nkidney, esophagus, prostate, pancreas, and
\nrectum.<\/p>\n
“The inclusion of the IRE-Procedures for
\ndifferent types of tissue into the German
\nOPS-Catalogue highlights the relevance of
\nthis novel treatment method,” added Dr.
\nPhilipp Wiggerman, of University Hospital
\nin Regensburg, Germany.<\/p>\n
The pathway to a reimbursement code
\nfor a medical device in Germany can take a
\nyear or more as it requires multiple agency
\nfilings and support from each scientific
\nsociety that treats specific disease states.<\/p>\n
The G-DRG for NanoKnife is expected by
\nJan. 1, with reimbursement occurring as
\nearly as April as facilities go through their
\nindividual applications for reimbursement.<\/p>\n
AngioDynamics’ product lines include
\nablation systems, fluid management
\nsystems, vascular access products, angiographic
\nproducts and accessories, angioplasty
\nproducts, drainage products, thrombolytic
\nproducts and venous products.<\/p>\n","protected":false},"excerpt":{"rendered":"
AngioDynamics, a leading provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the Germany Ministry of Health has issued an OPS (a procedure classification code) for the company’s NanoKnife System. This process…<\/p>\n","protected":false},"author":88,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[66,91,121],"yoast_head":"\r\n